Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study

• P. R. Bourque ,

  * E-mail: pbourque@toh.ca

  Affiliations The Ottawa Hospital, Department of Medicine, Division of Neurology, Ottawa, Canada, University of Ottawa, Faculty of Medicine, Ottawa, Canada

  ⨯
• C. E. Pringle,

  Affiliations The Ottawa Hospital, Department of Medicine, Division of Neurology, Ottawa, Canada, University of Ottawa, Faculty of Medicine, Ottawa, Canada

  ⨯
• W. Cameron,

  Affiliations University of Ottawa, Faculty of Medicine, Ottawa, Canada, The Ottawa Hospital, Department of Medicine, Division of Infectious Diseases, Ottawa, Canada, The Ottawa Hospital Research Institute, Ottawa, Canada

  ⨯
• J. Cowan,

  Affiliations University of Ottawa, Faculty of Medicine, Ottawa, Canada, The Ottawa Hospital, Department of Medicine, Division of Infectious Diseases, Ottawa, Canada

  ⨯
• J. Warman Chardon

  Affiliations The Ottawa Hospital, Department of Medicine, Division of Neurology, Ottawa, Canada, University of Ottawa, Faculty of Medicine, Ottawa, Canada, The Ottawa Hospital Research Institute, Ottawa, Canada, Children’s Hospital of Eastern Ontario, Division of Genetics, Ottawa, Canada

  ⨯